首页> 美国卫生研究院文献>Materials Today Bio >A melt-electrowritten filter for capture and culture of circulating colon cancer cells
【2h】

A melt-electrowritten filter for capture and culture of circulating colon cancer cells

机译:用于捕获和培养循环结肠癌细胞的熔融电子过滤器

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。
获取外文期刊封面目录资料

摘要

Metastasis is the major cause of death in cancer patients accounting for about 90% of the mortality. The detection and analysis of the hallmark of metastasis, circulating tumor cells (CTCs), have significant impact in cancer biology and clinical practice. However, the scarcity of CTCs in blood, particularly in that of colorectal cancer patients, is a serious bottleneck in the development of CTC-based precision medicine. Herein, the melt electrowriting (MEW) technology was used for reproductive fabrication of a biocompatible antibody-presenting polycaprolactone filter with tailored porous structure. It is demonstrated, for the first time, that such filter can be used not only to catch cancer cells spiked in whole blood but also to culture the cancer cells directly . Specifically, HT29 colon cancer cells can be captured with an efficiency of 85%, and when spiked into 4 mL of whole blood, 47% were captured on one Ø12mm filter. Furthermore, repeated capture and culture experiments have shown that as few as 20 HT29 colon cancer cells spiked into 4 mL of whole blood can be captured on the filter and within 2 weeks be expanded to become tumor bodies that are visible to the untrained eye. This filter allows for downstream analysis, such as flow cytometry, immunocytochemistry, Western blotting, and rt-qPCR. This technology represents a simple and cost-effective platform that potentially enables fast and efficient culture of rare CTCs from patients’ blood. This provides non-invasive alternatives for solid biopsy tumor materials for treatment screening, with great potential to realize precision medicine for cancer treatment.
机译:转移是癌症患者的主要死亡原因,约占死亡率的90%。对转移标志,循环肿瘤细胞(CTC)的检测和分析对癌症生物学和临床实践具有重大影响。然而,血液中四氯化碳的缺乏,特别是大肠癌患者的缺乏,是基于四氯化碳的精密医学发展的严重瓶颈。在这里,熔体电写(MEW)技术用于具有定制多孔结构的生物相容性抗体呈递聚己内酯过滤器的繁殖制造。首次证明,这种过滤器不仅可以用于捕获掺入全血中的癌细胞,而且可以直接培养癌细胞。具体而言,HT29结肠癌细胞的捕获效率为85%,当掺入4mL全血时,在一个Ø12mm过滤器上捕获了47%。此外,重复的捕获和培养实验表明,掺入4mL全血的少至20枚HT29结肠癌细胞可以在过滤器上捕获,并在2周内扩展成为未经训练的眼睛可见的肿瘤体。该过滤器可用于下游分析,例如流式细胞仪,免疫细胞化学,蛋白质印迹和rt-qPCR。这项技术代表了一个简单且具有成本效益的平台,可以潜在地实现对患者血液中稀有CTC的快速高效培养。这为实体活检肿瘤材料的治疗筛选提供了非侵入性替代方法,具有实现癌症精确治疗的巨大潜力。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号